“Cytogenetic Analysis of HER2 in Ovarian Cancer Patients by Fluorescence in Situ Hybridization”, Eur. j., eng. sci., tech., vol. 3, no. 1, pp. 1–7, Oct. 2020, doi: 10.33422/ejest.v3i1.154.